CBLB and cholangiocarcinoma: Reports about FOXE1 and CBLB mutations in CCA are lacking so far but FOXE1 was described as a new susceptibility locus in thyroid cancer39 and CBLB gene mutations were reported to be associated with multi-chemoresistance in breast cancer cell-lines40.